Euglycemic diabetic ketoacidosis associated with SGLT2i use: Case series > 2021

본문 바로가기

접속자집계

오늘
1,606
전체
2,137,800
TEL:02-3789-7891
사이트 내 전체검색

Home >
2021

Euglycemic diabetic ketoacidosis associated with SGLT2i use: Case seri…

작성자 채식영양
작성일 21-01-01 00:00 | 조회 0 | 댓글 0

본문

HA. Puls, NL. Haas, BJ. Franklin, N. Theyyunni and CE. Harvey (2021). Euglycemic diabetic ketoacidosis associated with SGLT2i use: Case series. The American journal of emergency medicine, 44, 11-13. https://doi.org/10.1016/j.ajem.2021.01.033

PubMed 33571749


[Abstract]
INTRODUCTION: Euglycemic diabetic ketoacidosis (EuDKA) associated with Sodium-Glucose Cotransporter-2 inhibitor (SGLT2i) use has been described but remains poorly understood. Data on Emergency Department (ED) presentation, resource utilization, and safety outcomes for these patients are lacking. We report a case series of patients diagnosed with EuDKA in the ED.

METHODS: An electronic medical record search identified adult patients presenting to a large tertiary ED with EuDKA. They were screened for concurrent use of SGLT2i. Clinical presentation, resource utilization, safety, and disposition data were collected and described.

RESULTS: Five patients were included for analysis. Median age [range] was 57 [43-73] years. Presenting symptoms included nausea, vomiting, fatigue, and altered mental status. Initial results included: serum glucose 191 mg/dL [176-215], venous pH 7.01 [6.95-7.30], serum HCO3 8 mEq/L [6-13], anion gap 27 [26-31], serum beta-hydroxybutyrate 9.9 mmol/L [9.2-12.3], and urine ketones 150 [150-150]. Patients remained on an insulin infusion for 18.77 h [11.25-56.48]. There were zero episodes of hypoglycemia and one episode of hypokalemia while on insulin infusion. Time to resolution of metabolic acidosis was 23.82 h [15.45-24.77].

DISCUSSION: We report a case series of ED patients with EuDKA associated with SGLT2i use, and describe presentation characteristics, resource utilization, and safety outcomes. Emergency physicians should be aware of the association between SGLT2i use and EuDKA. An appropriate work-up should be pursued for patients taking an SGLT2i who present with symptoms suggestive of DKA, including nausea, vomiting, malaise, and altered mental status, or are noted to have an unexplained elevated anion gap metabolic acidosis.

0
  • 페이스북으로 보내기
  • 트위터로 보내기
  • 구글플러스로 보내기

댓글목록 0

등록된 댓글이 없습니다.

Total 383
2021 목록
번호 제목 글쓴이 날짜 조회 추천
353 텍스트 Potassium Concentration in Initial Fluid Therapy and In-Hosp… 링크 채식영양 01-01 1 0
352 텍스트 Euglycaemic diabetic ketoacidosis in a 43-year-old woman wit… 링크 채식영양 01-01 1 0
351 텍스트 Intraoperative Diagnosis of Sodium-Glucose Cotransporter 2 I… 링크 채식영양 01-01 0 0
350 텍스트 Immune checkpoint inhibitor-induced takotsubo syndrome and d… 링크 채식영양 01-01 0 0
349 텍스트 Diabetic Ketoacidosis in the Preterm Gestation 링크 채식영양 01-01 0 0
348 텍스트 Previous diabetic ketoacidosis as a risk factor for recurren… 링크 채식영양 01-01 1 0
347 텍스트 Bedside sonographic measurements of optic nerve sheath diame… 링크 채식영양 01-01 0 0
346 텍스트 COVID-19 and Diabetic Ketoacidosis: A Single Center Experien… 링크 채식영양 01-01 0 0
345 텍스트 Euglycemic Diabetic Ketoacidosis in a Patient Prescribed Emp… 링크 채식영양 01-01 1 0
344 텍스트 Euglycemic Ketoacidosis as a Complication of SGLT2 Inhibitor… 링크 채식영양 01-01 0 0
343 텍스트 Identifying Risk Factors for Diabetic Ketoacidosis Associate… 링크 채식영양 01-01 0 0
342 텍스트 Pancreatic Enzyme Elevation Patterns in Patients With Diabet… 링크 채식영양 01-01 1 0
341 텍스트 Immediate Euglycemic Diabetic Ketoacidosis After Gastric Byp… 링크 채식영양 01-01 0 0
열람중 텍스트 Euglycemic diabetic ketoacidosis associated with SGLT2i use:… 링크 채식영양 01-01 1 0
339 텍스트 Severe ketoacidosis in a lactating woman on a ketogenic diet 링크 채식영양 01-01 0 0
게시물 검색

한국채식정보. 대표:이광조ㅣsoypaper@hanmail.netㅣ대표전화: 02-3789-7891ㅣ서울시 용산구 갈월동 56-5. 일심빌딩 203호